Navigation Links
Arisaph Pharmaceuticals Awarded Phase I STTR Grant To Develop Small Molecule Immune Modulators
Date:7/31/2013

BOSTON, July 31, 2013 /PRNewswire/ -- Arisaph Pharmaceuticals, Inc., a privately held drug discovery and development biopharmaceutical company focused on developing novel therapies for cardiometabolic diseases and cancer, announced today that it has been awarded a Phase I Small Business Technology Transfer  (STTR) award from the National Cancer Institute of the National Institutes of Health. The Phase 1 award supports the research and development of Arisaph's small molecule immune modulators to stimulate tumor immunity following treatment with BRAF inhibitors in cancer. Following the successful completion of the research, the Company may be eligible for up to $2 million of additional Phase 2 funding to further the development of its immune modulator program for the treatment of melanoma. To date, Arisaph has received in excess of $55 million of non-dilutive capital, including $2.8 million awarded under the U.S. government's Therapeutics Discovery Project Program (TDPP) and $37 million from royalty monetizations leveraging the Company's DPP 4 inhibitor patent estate.

(Logo: http://photos.prnewswire.com/prnh/20110321/NE69091LOGO )

"We are delighted to receive our third small business grant from the NIH in support of our promising oncology programs, which could enhance the efficacy of existing therapies, such as BRAF inhibitors, for the treatment of melanoma," said Christopher P. Kiritsy, President and Chief Executive Officer. "This award continues the string of government grants and other non-dilutive support, enabling the Company to advance its pipeline in an investor friendly manner."

Arisaph has leveraged its medicinal chemistry expertise to develop a class of small molecule immune modulators to boost the immune system to fight various cancers. Such immune modulators are expected to enhance the efficacy of various
'/>"/>

SOURCE Arisaph Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Arisaph Pharmaceuticals Reports Positive Results From Two Safety Clinical Trials For Its Niacin Analog (ARI-3037MO)
2. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
3. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
4. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
5. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
6. Icahn Issues Statement Regarding Amylin Pharmaceuticals
7. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
8. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
9. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
10. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
11. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ) today reported ... the three and six months ended June 30, 2015, ... and $43.4 million for the same periods in 2014. ... the more than $90 million of revenue Isis earned ... from Bayer to license  ISIS-FXI Rx .  Isis increased ...
(Date:8/4/2015)... -- Intec Pharma Ltd. (the "Company") (NASDAQ: NTEC ), ... based on its proprietary Accordion Pill platform technology, today ... the United States of 5,025,000 ... public of $6.00 per ordinary share, before underwriting discounts ... offered by the Company.  In addition, the Company has ...
(Date:8/4/2015)... 4, 2015 Transparency Market Research ... Testing (NIPT) Market (BambniTest, Harmony, informaSeq, MaterniT21 PLUS, NIFTY, ... Analysis, Size, Volume, Share, Growth, Trends and Forecast 2014 ... market report published by Transparency Market Research " Non-invasive ... Share, Growth, Trends and Forecast 2014 - 2022 ", ...
Breaking Medicine Technology:Isis Reports Financial Results And Highlights For Second Quarter 2015 2Isis Reports Financial Results And Highlights For Second Quarter 2015 3Isis Reports Financial Results And Highlights For Second Quarter 2015 4Isis Reports Financial Results And Highlights For Second Quarter 2015 5Isis Reports Financial Results And Highlights For Second Quarter 2015 6Isis Reports Financial Results And Highlights For Second Quarter 2015 7Isis Reports Financial Results And Highlights For Second Quarter 2015 8Isis Reports Financial Results And Highlights For Second Quarter 2015 9Isis Reports Financial Results And Highlights For Second Quarter 2015 10Isis Reports Financial Results And Highlights For Second Quarter 2015 11Isis Reports Financial Results And Highlights For Second Quarter 2015 12Isis Reports Financial Results And Highlights For Second Quarter 2015 13Isis Reports Financial Results And Highlights For Second Quarter 2015 14Isis Reports Financial Results And Highlights For Second Quarter 2015 15Isis Reports Financial Results And Highlights For Second Quarter 2015 16Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering 2Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering 3Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 2Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 3Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 4Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 5
... SAN DIEGO, Nov. 4 Orexigen® Therapeutics, Inc. (Nasdaq: ... treatment of obesity, today announced unaudited financial results for ... Three Months Ended September 30, 2009 , ... in cash and cash equivalents and an additional $50.9 ...
... Technologies, manufacturer of custom fluid handling fiber and foam ... a division of UK-based Filtrona plc (Pink Sheets: FLRAF), ... select medical and personal care markets, specifically wound care. ... patent-pending foam-fiber composite consists of a soft, highly absorbent ...
Cached Medicine Technology:Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 2Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 3Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 4Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 5Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 6Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 7Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 8Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 9Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results 10Filtrona Porous Technologies Realizes Innovative New Product Development Through Foam-Fiber Technology Synergy : Introducing MediSponge(R) RBR Wound Care Dressings 2
(Date:8/4/2015)... ... 2015 , ... How cool is it to check in at your favorite ... "Now" feature will soon allow you to do just that. , Ahhaa is releasing ... the now feature. , Users will soon get to share what inspires them about ...
(Date:8/4/2015)... ... August 04, 2015 , ... World Patent ... Dumbbell Bench Rack, a fitness invention that eliminates the need to have a ... and Fitness Clubs industry is worth $30 billion," says Scott Cooper, CEO and ...
(Date:8/4/2015)... ... 04, 2015 , ... The United Nations Foundation today announced ... Indonesia for a select group of U.S.-based journalists during the week of November ... the International Conference on Family Planning in Bali. , In close coordination ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... An ... found financial incentives to be a viable method for encouraging people to lose weight. ... on the future of their weight loss success, adding a financial incentive to the ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... suffering from underarm sweat. Evolutions Medical & Day Spa in Santa Barbara, CA ... only non-invasive, FDA cleared treatment that permanently eliminates sweat and odor glands in ...
Breaking Medicine News(10 mins):Health News:Ahhaa App Soon to Release the "Now" Feature 2Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 2Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 3Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 4Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 5Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 6Health News:UN Foundation Announces Press Fellowship to Indonesia with Focus on Women’s Health and Rights 2Health News:Article on Incentivizing Weight Loss Mirrors Similar Motivations Surrounding Weight Loss Surgery, Says Dr. Feiz & Associates 2Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 2Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 3
... ... Hill Village will participate in the first-ever virtual classroom presentation of Mindfulness and Chocolate. ... Internet, will conduct the two-hour session. The class is designed to raise a participant,s ... ...
... ... and Siemens Home Appliance Group,s Protos Stove to local communities living near its Jatropha ... Oil to fuel the stoves. , ... (PRWEB) May 25, 2010 -- Indonesia based PT Waterland International ...
... and acceptance Three new reports describe biomarkers ... excellent and stable allograft function in the absence of ... transplants. Peter Heeger and Bernd Schrppel, at Mount Sinai ... commentary, the importance of these studies and how they ...
... their quality of life, researchers say , MONDAY, May ... of life as being as good as that of ... finding suggests that despite the numerous challenges they face ... social stigma and the effects of medication, children with ...
... a distinct pattern of gene expression in the largest ... rejected the transplant kidneys even though they stopped taking ... recipients who could safely reduce or end use of ... the United States were living with a kidney transplant. ...
... flu shot, expert says , MONDAY, May 24 (HealthDay News) -- ... at high risk of experiencing serious complications for themselves and their ... there has not been much data about the effect of the ... data exists is conflicting. In other pandemic flus -- in 1918 ...
Cached Medicine News:Health News:eMindful Provides a New Twist on Chocolate for Members of Boston's Beacon Hill Village 2Health News:Waterland International Together with Bosch and Siemens Home Appliance Group (BSH) Continue to Help Local Communities in Indonesia 2Health News:Waterland International Together with Bosch and Siemens Home Appliance Group (BSH) Continue to Help Local Communities in Indonesia 3Health News:JCI table of contents: May 24, 2010 2Health News:JCI table of contents: May 24, 2010 3Health News:JCI table of contents: May 24, 2010 4Health News:JCI table of contents: May 24, 2010 5Health News:JCI table of contents: May 24, 2010 6Health News:JCI table of contents: May 24, 2010 7Health News:JCI table of contents: May 24, 2010 8Health News:JCI table of contents: May 24, 2010 9Health News:Children With Epilepsy Feel on Par With Healthy Siblings 2Health News:Gene pattern may identify kidney transplant recipients who don't need life-long anti-rejection drugs 2Health News:Gene pattern may identify kidney transplant recipients who don't need life-long anti-rejection drugs 3Health News:Gene pattern may identify kidney transplant recipients who don't need life-long anti-rejection drugs 4Health News:H1N1 Pandemic Flu Hits Pregnant Women Hard 2
... The Appose Single Use Skin Staple ... tip extractor design that is packaged ... used to remove skin staples. The ... jaws of the extractor under the ...
... Staplers place single staples to close ... lubricant-coated stainless steel; the staplers are ... different skin staplers to meet your ... applications for routine skin closure in ...
... a full-feature skin stapler with a 360° ... improved visibility over existing fixed-head skin stapling ... easier staple placement., ,This Skin Stapler ... designed to deliver rectangular, stainless steel staples ...
... 55 Articulating Linear Staplers are available with ... thick-tissue green instrument (non-reloadable). Each instrument contains ... line., ,Benefits include: , Small profile ... male pelvis. , Articulating head rotates up ...
Medicine Products: